- Home
- KROS vs ECX Comparison
KROS vs ECX Comparison
Compare KROS & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- ECX
- Stock Information
- Founded
- KROS 2015
- ECX 2017
- Country
- KROS United States
- ECX China
- Employees
- KROS N/A
- ECX N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- ECX EDP Services
- Sector
- KROS Health Care
- ECX Technology
- Exchange
- KROS Nasdaq
- ECX Nasdaq
- Market Cap
- KROS 558.9M
- ECX 589.5M
- IPO Year
- KROS 2020
- ECX N/A
- Fundamental
- Price
- KROS $13.45
- ECX $2.19
- Analyst Decision
- KROS Buy
- ECX Strong Buy
- Analyst Count
- KROS 13
- ECX 1
- Target Price
- KROS $20.63
- ECX $3.20
- AVG Volume (30 Days)
- KROS 603.2K
- ECX 2.7M
- Earning Date
- KROS 08-06-2025
- ECX 08-07-2025
- Dividend Yield
- KROS N/A
- ECX N/A
- EPS Growth
- KROS N/A
- ECX N/A
- EPS
- KROS 0.11
- ECX N/A
- Revenue
- KROS $214,713,000.00
- ECX $805,604,079.00
- Revenue This Year
- KROS $5,006.76
- ECX $26.72
- Revenue Next Year
- KROS N/A
- ECX $30.34
- P/E Ratio
- KROS $123.44
- ECX N/A
- Revenue Growth
- KROS 91657.70
- ECX 19.98
- 52 Week Low
- KROS $9.12
- ECX $0.76
- 52 Week High
- KROS $72.37
- ECX $3.25
- Technical
- Relative Strength Index (RSI)
- KROS 45.45
- ECX 73.84
- Support Level
- KROS $13.24
- ECX $1.62
- Resistance Level
- KROS $13.77
- ECX $1.96
- Average True Range (ATR)
- KROS 0.37
- ECX 0.15
- MACD
- KROS -0.04
- ECX 0.05
- Stochastic Oscillator
- KROS 38.67
- ECX 86.86
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.